Ashvattha Therapeutics
Updated: March 19, 2026
Founder Jeffrey Cleland
Country: USA | Funding: $148M (+)
Founded: 2015
Website: http://avttx.com/
Ashvattha Therapeutics develops therapy thar selectively targets hyper-inflammatory macrophages responsible for excessive cytokine production in severe COVID-19 patients.
Founded: 2015
Website: http://avttx.com/
Ashvattha Therapeutics develops therapy thar selectively targets hyper-inflammatory macrophages responsible for excessive cytokine production in severe COVID-19 patients.
